Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'fiin 3'

Search results for: 'fiin 3'

Items 1-10 of 181

Page
per page
  1. 3-Methyladenine
    A8353 3-Methyladenine
     3 Citation
    Target: PI3K
    Summary: Class III PI3K inhibitor
      ≥5 mg/mL
  2. Nutlin-3
    A4228 Nutlin-3
    Target: MDM2
    Summary: MDM2 antagonist,inhibits MDM2-p53 interaction
      ≥58.2 mg/mL
  3. 3-Deazaneplanocin,DZNep
    A1905 3-Deazaneplanocin,DZNep
     6 Citation
    Target: Hydrolase
    Summary: S-adenosylhomocysteine and EZH2 inhibitor
      insoluble in EtOH; ≥17.07 mg/mL
  4. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL
  5. IPA-3
    B2169 IPA-3
     1 Citation
    Target: PAK
    Summary: Non-ATP competitive Pak1 inhibitor
      insoluble in H2O; ≥16.1 mg/mL
  6. CORM-3
    B3060 CORM-3
     1 Citation
    Summary: Exhibits anti-inflammatory/cardioprotective effects
      ≥29.5 mg/mL
  7. Ansamitocin P-3
    A3183 Ansamitocin P-3
    Target: Microtubules/Tubulins
    Summary: Inhibitor of tublin spiralization,maytansine analog
      ≥31.75 mg/mL
  8. Peptide YY(3-36), PYY, human
    A1115 Peptide YY(3-36), PYY, human
    Target: NPY Receptors
    Summary: Y2R agonist
      ≥405 mg/mL
  9. Exendin-3 (9-39) amide
    B6943 Exendin-3 (9-39) amide
     1 Citation
    Target: Glucagon-like peptide 1 (GLP-1) receptors
    Summary: GLP-1 receptor antagonist
      ≥168.5 mg/mL
  10. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL

Items 1-10 of 181

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 174item
  2. Cell Biology 1 item
  3. Lab Reagents 4item
Reversibility
  1. Reversible 10item
  2. Irreversible 3item
Target
  1. Caspases 3item
  2. Cyclin-Dependent Kinases 6item
  3. Histone Deacetylases (HDACs) 4item
  4. Inhibitor of apoptosis proteins (IAP) 1 item
  5. Akt 3item
  6. PI3K 11item
  7. CXCR 2item
  8. Raf 1 item
  9. Aurora Kinases 4item
  10. MDM2 1 item
  11. EZH2 1 item
  12. mTOR 1 item
  13. AP-1 1 item
  14. MMP 4item
  15. Peptidylprolyl isomerases 1 item
  16. DT-diaphorases 1 item
  17. MER 1 item
  18. FLT3 7item
  19. GSK-3 6item
  20. Factor Xa 1 item
  21. LPA Receptors 1 item
  22. P-glycoprotein (P-gp) 3item
  23. PLK 2item
  24. Chk 2item
  25. VEGFR 11item
  26. PDGFR 9item
  27. c-Kit 4item
  28. RET 2item
  29. Phosphodiesterases (PDEs) 1 item
  30. Mcl-1 1 item
  31. Hydrolase 1 item
  32. p38 3item
  33. PKB 1 item
  34. JNK 1 item
  35. SGK 1 item
  36. Bcr-Abl 1 item
  37. Kynurenine-3-monooxygenase 1 item
  38. MEK 3item
  39. FGFR 4item
  40. Nrf2 1 item
  41. Pim 1 item
  42. Liver X receptors (LXRs) 1 item
  43. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  44. Voltage-gated Sodium (NaV) Channels 1 item
  45. Deubiquitinating enzymes (DUBs) 2item
  46. PP1 1 item
  47. PP2A 1 item
  48. Smoothened 1 item
  49. MET 2item
  50. Src 1 item
  51. Trk Receptors 1 item
  52. Aminopeptidases 1 item
  53. STAT 1 item
  54. Microtubules/Tubulins 2item
  55. Estrogen and Related Receptors 1 item
  56. EGFR 3item
  57. Hedgehog 1 item
  58. ROCK 2item
  59. RIP kinases 1 item
  60. Monocyte chemotactic proteins 1 item
  61. PAK 1 item
  62. JAK 3item
  63. Progesterone Receptors 1 item
  64. HSP90 2item
  65. AMPK 2item
  66. CFTR 2item
  67. TNKS 1 item
  68. Topoisomerases 3item
  69. ErbB 1 item
  70. Toll-like receptors (TLRs) 1 item
  71. ERK 1 item
  72. HMG-CoA Reductases 1 item
  73. c-MET 2item
  74. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  75. HER2 1 item
  76. USP 1 item
  77. 5-HT2 Receptors 1 item
  78. LRRK2 1 item
  79. DGAT 1 item
  80. PARP 1 item
  81. ALK 1 item
  82. CETP 1 item
  83. BCPCF efflux 1 item
  84. D2 Receptors 1 item
  85. 5-HT1 Receptors 1 item
  86. 5-HT7 Receptors 1 item
  87. AdipoR1 1 item
  88. AdipoR2 1 item
  89. Serotonin reuptake 1 item
  90. Insulin-like growth factors (IGFs) 1 item
  91. CSF1R 1 item
  92. MK2 2item
  93. 5-HT3 Receptors 1 item
  94. Angiotensin-Converting Enzymes (ACEs) 1 item
  95. Free Fatty Acid Receptors 1 item
  96. Histamine H4 Receptors 2item
  97. HIV Integrases 1 item
  98. P2X Receptors 1 item
  99. Ron 1 item
  100. Calcium-activated chloride channels (CaCC) 1 item
  101. GPR35 1 item
  102. MAGL 1 item
  103. NPY Receptors 1 item
  104. Histamine H1 Receptors 1 item
  105. Na /K ATPases 1 item
  106. Histamine H2 Receptors 1 item
  107. Phospholipases 1 item
  108. Glucocorticoid Receptors 2item
  109. IL Receptors 1 item
  110. CCL2 1 item
  111. 15-lipoxygenases 1 item
  112. AChE 1 item
  113. Insulin Receptors 1 item
  114. IRG-1R 1 item
  115. Inward Rectifier Potassium (Kir) Channels 1 item
  116. Cdc7 1 item
  117. Adenine receptors 1 item
  118. NAE 1 item
  119. Ubiquitin-activating Enzyme E1 1 item
  120. SUMOylation 1 item
  121. ATGL 1 item
  122. PP4 1 item
  123. c-RET 1 item
  124. HDAC 1 item
  125. human lyase 1 item
  126. IKK 1 item
  127. NOP Receptors 1 item
  128. Androgen Receptor 1 item
  129. Substance P/NK1 Receptor 1 item
  130. gp120/CD4 1 item
  131. Sirtuin 1 item
  132. CRF1 Receptors 1 item
Related Disease
  1. Acute Kidney Injury 1 item
  2. Acute Myelogenous Leukemia 1 item
  3. Acute Myeloid Leukemia 9item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 2item
  6. Breast Cancer 33item
  7. Cancer 90item
  8. Cervical Cancer 2item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Colon Cancer 10item
  12. Colon Carcinoma 2item
  13. Colorectal Cancer 12item
  14. Diabetes 1 item
  15. Dyskinesia 1 item
  16. Dyslipidemia 2item
  17. Erectile Dysfunction 1 item
  18. Friedreich's Ataxia 1 item
  19. Glioblastoma 7item
  20. Glioma 4item
  21. Heart Failure 1 item
  22. HIV 2item
  23. HIV Infections 1 item
  24. Inflammatory Diseases 5item
  25. Kidney Injury Studies 1 item
  26. Leukemia 5item
  27. Liver Cancer 1 item
  28. Lung Cancer 8item
  29. Lymphoma 3item
  30. Melanoma 7item
  31. Multiple Myeloma 4item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Narcolepsy 1 item
  35. Neuroblastoma 3item
  36. Non-small Cell Lung Cancer 5item
  37. Non-small Cell Lung Carcinoma 2item
  38. Ovarian Cancer 10item
  39. Pancreatic Cancer 9item
  40. Pancreatic Carcinoma 1 item
  41. Prostate Cancer 13item
  42. Psoriasis 1 item
  43. Pulmonary Arterial Hypertension 1 item
  44. Pulmonary Fibrosis 1 item
  45. Renal Cell Carcinoma 3item
  46. Rheumatoid Arthritis 2item
  47. Schizophrenia 2item
  48. Thyroid Cancer 2item
  49. Type 2 Diabetes 2item